“The current legal status of assisted dying is inadequate and incoherent...” The Commission on Assisted Dying was set up in September 2010 to consider whether the current legal and policy approach to assisted dying in England and Wales is fit for purpose. In addition to evaluating the strengths and weaknesses of the legal status quo, the Commission also set out to explore the question of what a framework for assisted dying might look like, if such a system were to be implemented in the UK, and what approach to assisted dying might be most acceptable to health and social care professionals and to the general public.
The treatment of inherited mitochondrial abnormalities in human embryos using donor mitochondria is an advancing area of research. The techniques involved could have profound implications for future generations. This project will explore the ethical issues relevant to affected families, potential donors, researchers, medical professionals and others trying to understand and respond to the therapeutic possibility of mitochondrial transfer.
Cash incentives and the payment of funeral expenses are two ideas being put forward to encourage people to donate human organs and tissue. The Nuffield Council on Bioethics is asking the public if it is ethical to use financial incentives to increase donations of organs, eggs and sperm. Paying for most types of organs and tissue is illegal in the UK. The public consultation will last 12 weeks and the council's findings will be published in autumn 2011.
The MDU has grave concerns about how the new policy* on whether or not to prosecute the offence of assisted suicide, will be applied to doctors. “The MDU’s advice to its members remains that doctors approached by patients for advice about suicide should not engage in discussion which assists the patient to that end. Members who are faced with requests for help from patients, including for example the provision of medical reports, should contact us for advice.”
A leading doctors’ organisation has today warned that doctors face a greater risk of prosecution for assisting a patient’s suicide following the publication of the DPP’s final Policy for Prosecutors in Respect of Cases of Encouraging or Assisting Suicide. The Medical Protection Society (MPS) – which provides indemnity, legal and professional support to around half of all doctors in the UK – said that the new policy sends a clear signal that prosecutions are more likely to be brought against healthcare professionals in circumstances where they might have assisted a patient’s suicide. The organisation warned doctors to be extremely cautious when providing help or advice to patients who are considering assisted suicide.
The Galton Institute exists to promote the public understanding of human heredity and to facilitate informed debate about the ethical issues raised by advances in reproductive technology. It also publishes studies in the historical development of these topics. The Institute is a registered charity and does not seek to advocate particular applications of scientific understanding or reproductive technology, only to ensure that those taking decisions do so in the light of all relevant facts and after consideration of all relevant issues. A fuller statement of the Institute's objectives is available elsewhere on this site.
Subsequent to an intensive three-year period of reflection, the CMQ is revealing its perspective and conclusions today regarding end-of-life care and euthanasia. The CMQ embraces the point of view of the patient who is confronting imminent and inevitable death. In such a situation, the patient looks to their physician and generally requests that they be able to die without undue suffering and with dignity. Neither surveys, nor attorneys, nor politicians can properly advise the physician and the patient facing this situation. In the majority of cases, the patient and their doctor find the appropriate analgesia that respects the ethical obligation of physicians not to preserve life at any cost, but rather, when the death of a patient appears to be inevitable, to act so that it occurs with dignity and to ensure that the patient obtains the appropriate support and relief.
The Emerging Science and Bioethics Advisory Committee (ESBAC) was the main UK advisory body on emerging healthcare scientific developments and their ethical, legal, social and economic implications. It was sponsored by the Chief Medical Officer (CMO) for the Department of Health (DH), England. Its membership included representation from all UK Health Departments for whom ESBAC also provided advice. ESBAC also provided a forum to consider and develop coordinated advice across the wider science, health and academic communities to help set priorities in response to new developments.
Rechtsonzekerheid voor artsen bij uitvoering euthanasie onacceptabel Artsen houden zich goed aan de euthanasiewet, zo blijkt uit de tweede evaluatie van deze wet. Maar zij worden geconfronteerd met rechtsonzekerheid over het toetsingskader. Daarom steunt de KNMG de aanbeveling van een code of practice voor de toetsingscommissies en dringt zij aan op duidelijkheid over de waarde van de schriftelijke wilsverklaring bij wilsonbekwame patiënten. De KNMG reageert hiermee op de tweede evaluatie van de Wet toetsing levensbeëindiging op verzoek en hulp bij zelfdoding (Wtl).
Un débat interne à l’ensemble de l’Institution ordinale a été conduit avant cette expression publique. Il en résulte que la fin de la vie d’une personne dans ces situations implique profondément le corps médical selon les principes éthiques de bienfaisance et d’humanité. L’Ordre national des médecins propose donc de promouvoir une meilleure connaissance de la loi Leonetti et d’envisager des améliorations susceptibles de répondre à des situations exceptionnelles. L’Ordre national des médecins apportera sa contribution au débat sociétal quant à l’euthanasie délibérée et au suicide assisté.
The setting up of the National Bioethics Committee followed resolution no. 6-00038 approved on 5 July 1988 in which the Chamber of Deputies, among other things, committed the Government to promoting an international level comparison on the state of the art of biomedical research and genetic engineering which might serve as a valid point of reference for future choices in which the progress of science can be reconciled with the respect for human freedom and dignity